Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review. Journal of the American College of Cardiology Samuels, B. A., Shah, S. M., Widmer, R. J., Kobayashi, Y., Miner, S. E., Taqueti, V. R., Jeremias, A., Albadri, A., Blair, J. A., Kearney, K. E., Wei, J., Park, K., Barseghian El-Farra, A., Holoshitz, N., Janaszek, K. B., Kesarwani, M., Lerman, A., Prasad, M., Quesada, O., Reynolds, H. R., Savage, M. P., Smilowitz, N. R., Sutton, N. R., Sweeny, J. M., Toleva, O., Henry, T. D., Moses, J. W., Fearon, W. F., Tremmel, J. A. 2023; 82 (12): 1245-1263

Abstract

Angina with nonobstructive coronary arteries (ANOCA) is increasingly recognized and may affect nearly one-half of patients undergoing invasive coronary angiography for suspected ischemic heart disease. This working diagnosis encompasses coronary microvascular dysfunction, microvascular and epicardial spasm, myocardial bridging, and other occult coronary abnormalities. Patients with ANOCA often face a high burden of symptoms and may experience repeated presentations to multiple medical providers before receiving a diagnosis. Given the challenges of establishing a diagnosis, patients with ANOCA frequently experience invalidation and recidivism, possibly leading to anxiety and depression. Advances in scientific knowledge and diagnostic testing now allow for routine evaluation of ANOCA noninvasively and in the cardiac catheterization laboratory with coronary function testing (CFT). CFT includes diagnostic coronary angiography, assessment of coronary flow reserve and microcirculatory resistance, provocative testing for endothelial dysfunction and coronary vasospasm, and intravascular imaging for identification of myocardial bridging, with hemodynamic assessment as needed.

View details for DOI 10.1016/j.jacc.2023.06.043

View details for PubMedID 37704315